Obesity
📧 Sign up to get email alerts when something new happens for Obesity.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-17Clinical Trial Update: Tailoring Obesity Treatment Trial [Phase 2, Phase 3]
A Phase 2/3 trial titled 'Tailoring Obesity Treatment' sponsored by Esbjerg Hospital – University Hospital of Southern Denmark has been with…
-
CLINICAL_TRIALS withdrawal · 2026-04-15Clinical Trial Update: Isoleucine Addition Treatment Effects in a Controlled Diet Study [NA]
A clinical trial evaluating the addition of the amino acid isoleucine to a controlled diet for individuals with prediabetes and metabolic sy…
-
CLINICAL_TRIALS withdrawal · 2026-03-04Clinical Trial Update: Families, Responsibility, Education, Support, and Health for Executive Function [NA]
Clinical trial NCT05165511 (University of California, San Diego) on overweight/obesity and ADHD was withdrawn; no drug intervention is liste…
-
CLINICAL_TRIALS withdrawal · 2026-02-25Clinical Trial Update: A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM [Phase 2]
Phase 2 study evaluating HT-6184 in combination with semaglutide for obese participants with type 2 diabetes has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-20Clinical Trial Update: Effects of Different PEEP Levels on Work of Breathing in Morbidly Obese Patients Prior to and After Extubation [NA]
The clinical trial evaluating the effects of different PEEP levels on work of breathing in morbidly obese patients before and after extubati…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2026-02-17Clinical Trial Update: Composite Dietary Antioxidant Index and Metabolic Health in Overweight/Obesity in U.S. Adults
A clinical trial evaluating the relationship between the Composite Dietary Antioxidant Index and metabolic health in overweight/obese U.S. a…
-
CLINICAL_TRIALS withdrawal · 2026-01-12Clinical Trial Update: Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk [NA]
The clinical trial NCT03000803 evaluating circadian variation of endocannabinoid levels and obesity risk has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-12-30Clinical Trial Update: Gamification to Increase Mobility in the Hospital [NA]
The clinical trial NCT04300764 evaluating gamification to increase mobility in hospitalized patients has been withdrawn. The sponsor is the …
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: Examining the Effects of Morning and Evening Exercise on Glucose Regulation in Adults With Prediabetes [NA]
A clinical trial investigating morning versus evening exercise effects on glucose regulation in adults with prediabetes and obesity has been…
-
CLINICAL_TRIALS withdrawal · 2025-12-19Clinical Trial Update: The Effects of Semaglutide on Body Composition and Performance in Military Personnel [Phase 4]
A Phase 4 trial evaluating semaglutide for obesity in military personnel has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-12-19Clinical Trial Update: Machine Learning and 3D Image-Based Modeling for Real-Time Body Weight and Body Composition Estimation During Emergency Medical Care. Study 1
A clinical trial evaluating machine learning and 3D image-based modeling to estimate real-time body weight and body composition in emergency…
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight [Phase 3]
A Phase 3 trial evaluating sibutramine with extended-release topiramate in adults with overweight/obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-11-21Clinical Trial Update: Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity [NA]
A clinical trial investigating whether infant weight gain can be modulated to prevent obesity has been withdrawn from the registry; no resul…
-
CLINICAL_TRIALS withdrawal · 2025-11-20Clinical Trial Update: Treating Toddler Obesity by Treating the Parent/Caregiver Obesity With Weight Loss Medications [Phase 4]
This Phase 4 trial examining whether treating caregiver obesity with weight loss medications can reduce toddler obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-10-15Clinical Trial Update: Identifying Strategies to Curtail Weight Regain After GLP-1 Receptor Agonist Treatment Cessation [NA]
This clinical trial update reports termination of a study at the University of Texas Southwestern Medical Center that was investigating stra…
-
CLINICAL_TRIALS withdrawal · 2025-10-10Clinical Trial Update: Nutrition Optimization and Community Upliftment for Postpartum Recovery: Hypertension [NA]
The Johns Hopkins study on nutrition optimization for postpartum hypertension has been withdrawn. The listed conditions include obesity, pre…
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis [Phase 1]
A Phase 1 trial evaluating pharmacokinetics and pharmacodynamics of biologic drugs in obese patients with arthritis has been withdrawn, with…
-
CLINICAL_TRIALS withdrawal · 2025-09-24Clinical Trial Update: A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes [Phase 2]
A Phase 2 trial evaluating bimagrumab and tirzepatide, alone or in combination, in adults with obesity or overweight with Type 2 diabetes, h…
-
CLINICAL_TRIALS withdrawal · 2025-09-17Clinical Trial Update: Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women [Phase 1]
A Phase 1 clinical trial evaluating the safety and effects of Garetosmab in healthy obese men and postmenopausal women has been withdrawn. T…
-
CLINICAL_TRIALS withdrawal · 2025-09-11Clinical Trial Update: Combining HIIT and n-3 PUFA Supplementation to Reduce Inflammation and Improve Metabolic Health (HIIT&PUFA) [NA]
The HIIT&PUFA trial examining high-intensity interval training plus omega-3 fatty acid supplementation for obesity-related inflammation and …
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: Fit Child - Clinical Study on Weight Control [NA]
A pediatric weight-control clinical trial named Fit Child (NCT03196453) sponsored by Turku University Hospital has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-29Clinical Trial Update: Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese Individuals [Phase 1, Phase 2]
The Phase 1/Phase 2 trial evaluating a methylglyoxal-lowering cocktail for appetite reduction in obesity has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-11Clinical Trial Update: HEART Kitchen Pilot [NA]
The HEART Kitchen Pilot trial has been withdrawn, with no results or ongoing data reported in this update. No drug data or efficacy results …
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance [Phase 2]
A Phase 2 trial evaluating a GABA transaminase inhibitor to relieve obesity-induced hyperinsulinemia and insulin resistance has been withdra…
-
CLINICAL_TRIALS withdrawal · 2025-07-11Clinical Trial Update: Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic [NA]
A clinical trial evaluating the metabolic effects of polylactose as a novel prebiotic in pediatric obesity (adolescents and children) has be…